ASXC

ASXC - Asensus Surgical, Inc. Stock Price, Fair Value and News

$0.35 
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

ASXC Price Action

ASXC RSI Chart

ASXC Valuation

ASXC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ASXC Fundamentals

ASXC Revenue

ASXC Earnings

ASXC Profitability

ASXC Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20248.7M9.8M00
20237.0M7.1M5.6M8.6M
20227.2M7.1M7.1M7.1M
20214.7M5.1M6.9M8.2M
20207.0M4.0M2.8M3.2M
201921.5M18.8M15.4M8.5M
20189.9M14.7M20.0M24.1M
20173.6M5.0M3.8M7.1M
2016001.8M1.7M
20141.2M787.0K486.0K401.0K
20132.0M1.8M1.6M1.4M
20120002.1M
20100000
Get all data in R, Python etc through our Historical Stock Data APIs
ASXC
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.
 CEO
 WEBSITEasensus.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES183